摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-ethylsulfanylmethylene-pentane-2,4-dione | 29775-95-9

中文名称
——
中文别名
——
英文名称
3-ethylsulfanylmethylene-pentane-2,4-dione
英文别名
3-(Ethylsulfanylmethylidene)pentane-2,4-dione;3-(ethylsulfanylmethylidene)pentane-2,4-dione
3-ethylsulfanylmethylene-pentane-2,4-dione化学式
CAS
29775-95-9
化学式
C8H12O2S
mdl
——
分子量
172.248
InChiKey
QVCCEBFPXGLIKG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    11
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    59.4
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    参考文献:
    名称:
    二价硫化合物-铜(II)配合物与亲核试剂的缩合反应
    摘要:
    发现二价硫化合物如苯甲醛二乙基硫醇、二苯甲酮二乙基硫醇、原三硫代甲酸乙酯和苄基甲硫醚在氯化铜存在下与1,3-二羰基化合物、活性亚甲基化合物或苯甲醚的铜(II)盐反应,以良好的收率得到缩合或取代产物,并伴有碳硫键断裂。另一方面,在不存在氯化铜的情况下,二价硫化合物不发生反应,原料被回收。这些结果可以通过假设从二价硫化合物和铜 (II) 初始形成活性络合物来解释。
    DOI:
    10.1246/bcsj.43.2549
点击查看最新优质反应信息

文献信息

  • Inhibitors of Src and other protein kinases
    申请人:——
    公开号:US20030144309A1
    公开(公告)日:2003-07-31
    The present invention provides compounds of formula I: 1 wherein A is N or CR, and G, R 1 , R 2 and R 3 are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of Src mammalian protein kinase involved in cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
    本发明提供了式I的化合物: 其中A为N或CR,而G、R1、R2和R3如规范中所述。这些化合物是蛋白激酶的抑制剂,特别是涉及细胞增殖、细胞死亡和对细胞外刺激反应的哺乳动物Src蛋白激酶的抑制剂。该发明还涉及制备这些抑制剂的方法。该发明还提供了包括该发明的抑制剂的药物组合物以及利用这些组合物在治疗和预防各种疾病中的方法。
  • HETEROCYCLIC SUBSTITUTED PYRAZOLES AS INHIBITORS OF SRC AND OTHER PROTEIN KINASES
    申请人:VERTEX PHARMACEUTICALS INCORPORATED
    公开号:EP1404669A2
    公开(公告)日:2004-04-07
  • US6884804B2
    申请人:——
    公开号:US6884804B2
    公开(公告)日:2005-04-26
  • [EN] INHIBITORS OF SRC AND OTHER PROTEIN KINASES<br/>[FR] INHIBITEURS DE SRC ET AUTRES PROTEINE KINASES
    申请人:VERTEX PHARMA
    公开号:WO2002092573A2
    公开(公告)日:2002-11-21
    The present invention provides compounds of formula I:wherein A is N or CR, and G, R1, R2, and R3 are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of Src mammalian protein kinase involved in cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
  • The Condensation Reactions of Bivalent Sulfur Compounds-Copper(II) Complexes with Nucleophiles
    作者:Teruaki Mukaiyama、Koichi Narasaka、Kazuo Maekawa、Hisao Hokonoki
    DOI:10.1246/bcsj.43.2549
    日期:1970.8
    diethylmercaptal, benzophenone diethylmercaptole, ethyl orthotrithioformate and benzyl methylsulfide, react with copper(II) salts of 1,3-dicarbonyl compounds, active methylene compounds or anisole, in the presence of cupric chloride, to give condensation or substitution products in good yields accompanied with carbon-sulfur bond cleavage. On the other hand, in the absence of cupric chloride, the bivalent
    发现二价硫化合物如苯甲醛二乙基硫醇、二苯甲酮二乙基硫醇、原三硫代甲酸乙酯和苄基甲硫醚在氯化铜存在下与1,3-二羰基化合物、活性亚甲基化合物或苯甲醚的铜(II)盐反应,以良好的收率得到缩合或取代产物,并伴有碳硫键断裂。另一方面,在不存在氯化铜的情况下,二价硫化合物不发生反应,原料被回收。这些结果可以通过假设从二价硫化合物和铜 (II) 初始形成活性络合物来解释。
查看更多

同类化合物

甲酰四硫富瓦烯 环己酮,2-[二(甲硫基)亚甲基]- 5-乙基-2-甲基-噻吩-3-酮 4-羟基-2,5-二甲基噻吩-3(2H)-酮 4-乙基硫烷基-丁-3-烯-2-酮 4,4-二甲基-1,1-双(甲基硫代)-1-戊烯-3-酮 3-[双(甲基磺酰基)亚甲基]-2,4-戊二酮 3,3-双(甲硫基)-2-氰基丙烯酸乙酯 2-氰基-3,3-双(甲基硫代)丙烯酰胺 2-氰-3,3-二(甲硫基)丙烯酸甲酯 2-氯-3-氧代-2,3-二氢-2-噻吩羧酸甲酯 2-氨基-4,5-二氢-3-噻吩甲酰胺 2-乙酰基-3-氨基-3-甲基硫代丙烯腈 2-丙烯酸,3-(十六烷基硫代)-,甲基酯,(Z)- 2-(环丙基羰基)-3,3-二(甲基硫代)丙烯腈 2-(1,3-二噻戊环-2-亚基)环戊酮 2-(1,3-二噻戊环-2-亚基)环己酮 2,2-二甲基噻吩-3-酮 1-己烯-3-酮,1,1-二(甲硫基)-2-硝基- 1,3-二硫杂环戊烯-4-羧酸 (3Z)-1,1,1-三氟-4-(甲硫基)-3-丁烯-2-酮 (3E)-4-(甲硫基)-3-戊烯-2-酮 (2Z)-[3-(2-溴乙基)-4-氧代-1,3-噻唑烷-2-亚基]乙酸乙酯 (2Z)-2-(3-乙基-4-氧代-1,3-噻唑烷-2-亚基)乙酸乙酯 (2Z)-(3-甲基-4-氧代-1,3-噻唑烷-2-亚基)乙酸乙酯 (2E)-2-(4-氧代噻唑烷-2-亚基)乙酸丁酯 2-[bis(methylthio)methylene]-5-([13C]-methyl)cyclohexanone 2-Cyan-2-(2,3,4,5,6,7-hexahydrobenzothiazol-2-yliden)essigsaeuremethylester 2-(chlorodifluoromethylcarbonylmethylene)-1,3-thiazolidine 2,3-bis((S)-2-dodecyloxy-propanylthio)-6-(carboxy)tetrathiafulvalene 3-Amino-2-cyan-3-(ethylthio)acrylsaeuremethylester 5-dimethylaminomethylene-3-ethoxycarbonyl-2-methyl-4-oxo-4,5-dihydrothiophene 2-(1-methoxycarbonyl)trifluoroethylidene-1,3-dithiolane 2-(1-methoxycarbonyl)trifluoroethylidene-1,3-oxathiolane (Z)-4-(1-Butylthio)-but-3-en-2-one methyl 3-(butylthio)acrylate 3-Methylamino-3-methylmercapto-2-cyan-acrylsaeure-methylester 2-sec-butoxy-3,5-dimethylthiotetronic acid ethyl 2-amino-4-hydroxy-5-methyl-4-(trifluoromethyl)-4,5-dihydrothiophene-3-carboxylate cyano-(3-ethyl-4-oxo-thiazolidin-2-yliden)-acetic acid allyl ester 2‑(3,3‑dimethyl‑2‑oxobutylidene)‑1,3‑thiazolidin‑4‑one isopropyl 1,3-dithiol-2-ylidenemethylsulfonylacetate (E)-5-(furan-2-yl)-1,1-bis(methylthio)penta-1,4-dien-3-one ethyl 3-cyclohexylamino-3-methylthio-2-cyanoacrylate ethyl 2-ethoxy-4,5-dihydrothiophene-3-carboxylate 2,4-dimethyl-2,3-dihydro-thiophen-3-one isopropyl 2-(1,3-dithiol-2-ylidene)-2-(N-cyclohexylcarbamoyl)acetate 4,4-bis(methylthio)but-3-en-2-one-1,1,1,3-d4 N-(2-aminoethyl)-benzo[b]thieno[2,3-c]pyridine-3-carboamide.hydrochloride 3-(1,3-dithiolan-2-ylidene)butan-2-one